AB

Anne-Marie Beausoleil

TI Theravance Biopharma R&D Ip: 18 patents #16 of 116Top 15%
UB Unity Biotechnology: 8 patents #12 of 35Top 35%
CP Corvus Pharmaceuticals: 3 patents #6 of 20Top 30%
NT Neumora Therapeutics: 2 patents #10 of 36Top 30%
📍 Redwood City, CA: #245 of 5,061 inventorsTop 5%
🗺 California: #15,733 of 386,348 inventorsTop 5%
Overall (All Time): #109,740 of 4,157,543Top 3%
32
Patents All Time

Issued Patents All Time

Showing 26–32 of 32 patents

Patent #TitleCo-InventorsDate
10005740 Neprilysin inhibitors Melissa Fleury, Adam D. Hughes, Daniel D. Long, Donna A. A. Wilton 2018-06-26
9872855 (2R,4R)-5-(5′-Chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic acid Melissa Fleury, Adam D. Hughes, Erik Fenster, Venkat R. Thalladi, Miroslav Rapta 2018-01-23
9868698 (2S,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-4-(ethoxyoxalylamino)-2-hydroxymethyl-2-methylpentanoic acid Adam D. Hughes, Erik Fenster, Melissa Fleury, Venkat R. Thalladi, Jerry Nzerem +1 more 2018-01-16
9725470 Substituted naphthyridines as JAK kinase inhibitors Ryan Hudson, Jennifer Kozak, Paul R. Fatheree, Dante D. Podesto, Gary E. L. Brandt +1 more 2017-08-08
9670143 (2S,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-4-(ethoxyoxalylamino)-2-hydroxmethyl-2-methylpentanoic acid Adam D. Hughes, Erik Fenster, Melissa Fleury, Venkat R. Thalladi, Jerry Nzerem +1 more 2017-06-06
9533962 (2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic acid Melissa Fleury, Adam D. Hughes, Erik Fenster, Venkat R. Thalladi, Miroslav Rapta 2017-01-03
9433598 (2S,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-4-(ethoxyoxalylamino)-2-hydroxymethyl-2-methylpentanoic acid Adam D. Hughes, Erik Fenster, Melissa Fleury, Venkat R. Thalladi, Jerry Nzerem +1 more 2016-09-06